Christine Chan, MD

Gastroenterology
Accepting new patients
Sees patients age 18 and up
Penn Gastroenterology Perelman
View 1 additional location
Headshot of Christine Chan, MD
Penn Medicine Provider

About me

  • Clinical Assistant Professor of Medicine (Gastroenterology)

My education and training

  • Medical School: Albert Einstein College of Medicine
  • Residency: NewYork-Presbyterian/Columbia University Medical Center
  • Fellowship: Northwestern Memorial Hospital

Spoken languages

English
English

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Chan is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Hao, Jinxuan MD; Chan, Christine MD; Bittermann, Therese MD. Liver transplant immunosuppression education in the US: a survey of transplant hepatology fellowship program directors. Poster Presentation , AASLD liver meeting: 2024


Choi DK, Thaker S, West-Thielke P, Elmasri A, Chan C Evaluating the conversion to extended-release tacrolimus from immediate-release tacrolimus in liver transplant recipients , Eur J Gastroenterol Hepatol , 33(8): 2021,1124-8


Martin MT, Patel S, Kulik L, Chan C Glecaprevir/pibrentasvir + sofosbuvir + ribavirin offers high cure rate for hepatitis C virus retreatment in real-world settings , J Hepatol, 75(1): 2021,251-4


Choi DK, Martin MT, Chacra W, Chan C, Koppe S, Landers L, Naveed A, Mikolajczyk AE Practical considerations when treating chronic hepatitis E in solid organ transplant recipients , Int J Clin Pharm, 43(3): 2021,753-5


Agrawal, R, Ghoulam E, Nassani, N, Chan C Assessing the role of SGLT-2 inhibitors with diabetes and non-alcoholic fatty liver disease-a systematic review , Digestive Disease Week: 2021


Martin M, Tam FK, Bauer A, Chen YH, Waring N, Forrest J, Vitalo P, Lee TA, Koppe S, Chan C Hepatocellular carcinoma surveillance adherence after hepatitis C virus treatment at an urban academic center , Digestive Disease Week: 2021


Chan C, Schiano T, Agudelo E, Haydek JP, Hoteit M, Laurito MP, Norvell JP, Terrault N, Verna EC, Yang A, Levitsky J Immune-mediated graft dysfunction in liver transplant recipients with hepatitis C virus treated with direct-acting antiviral therapy , American Society of Transplantation, 18(10): 2018,2506-12


Chan C, Schiano T, Agudelo E, Haydek JP, Hoteit M, Laurito MP, Norvell JP, Terrault N, Verna EC, Yang A, Levitsky J Immune-mediated graft dysfunction in liver transplant recipients with hepatitis C virus treated with direct-acting antiviral therapy , Am J Transplant, 18(10): 2018,2506-12


Chan C, Schiano T, Agudelo E, Haydek JP, Hoteit M, Laurito MP, Norvell JP, Terrault N, Verna EC, Yang A, Levitsky J Immune-mediated graft dysfunction in liver transplant recipients with hepatitis C virus treated with direct-acting antiviral therapy , American Society of Transplantation, Seattle, WA: 2018


Chan C, Levitsky J Infection and Alcoholic Liver Disease , Clinics in Liver Disease, 20(3): 2016,595-06